Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

AXS Axis Capital Holders Limited
$104.87 1.97% +2.03
Notify me if price changes either direction
Interactive Brokers Logotype

Buy AXS stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Axis Capital Holders Limited (AXS)

Loading

Key Stats

Market cap. 7.5B
Enterprise value 8.4B
Trailing PE 7.9311404
Forward PE 7.781068
PEG Ratio 0.33046418333333
Enterprise to EBITDA 6.317
Enterprise to revenue 1.208
Price to book MRQ 1.3235106
Price to sales TTM 1.074476

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 6.9B
EBITDA 1.3B
Diluted EPS TTM 13.07
Total Cash (MRQ) 1.0B
Current ratio (MRQ) 0.682
Operating Cash Flow (TTM) 2.7B

AXS trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months
Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.